• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Lean non-alcoholic fatty liver disease: do not forget diabetes.

作者信息

Patoulias Dimitrios Ioannis, Kalogirou Maria-Styliani

机构信息

First Department of Internal Medicine, General Hospital "Hippokration", Thessaloniki, Greece.

Second Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, General Hospital "Hippokration", Thessaloniki, Greece.

出版信息

Arch Med Sci Atheroscler Dis. 2019 Dec 2;4:e248-e249. doi: 10.5114/amsad.2019.90146. eCollection 2019.

DOI:10.5114/amsad.2019.90146
PMID:32368679
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7191936/
Abstract
摘要

相似文献

1
Lean non-alcoholic fatty liver disease: do not forget diabetes.瘦型非酒精性脂肪性肝病：勿忘糖尿病。
Arch Med Sci Atheroscler Dis. 2019 Dec 2;4:e248-e249. doi: 10.5114/amsad.2019.90146. eCollection 2019.
2
Lean non-alcoholic fatty liver disease patients had comparable total caloric, carbohydrate, protein, fat, iron, sleep duration and overtime work as obese non-alcoholic fatty liver disease patients.瘦非酒精性脂肪性肝病患者的总热量、碳水化合物、蛋白质、脂肪、铁、睡眠时间和加班时间与肥胖非酒精性脂肪性肝病患者相当。
J Gastroenterol Hepatol. 2019 Jan;34(1):256-262. doi: 10.1111/jgh.14360. Epub 2018 Jul 16.
3
Lean non-alcoholic fatty liver disease (Lean-NAFLD): a major cause of cryptogenic liver disease.瘦型非酒精性脂肪性肝病（Lean-NAFLD）：隐源性肝病的主要病因。
Acta Gastroenterol Belg. 2011 Sep;74(3):389-94.
4
Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis.全球非肥胖或消瘦非酒精性脂肪性肝病的患病率、发病率和结局：系统评价和荟萃分析。
Lancet Gastroenterol Hepatol. 2020 Aug;5(8):739-752. doi: 10.1016/S2468-1253(20)30077-7. Epub 2020 May 12.
5
Non alcoholic fatty liver disease and risk of incident diabetes in subjects who are not obese.非酒精性脂肪性肝病与非肥胖人群中糖尿病发病风险的关系。
Nutr Metab Cardiovasc Dis. 2019 May;29(5):489-495. doi: 10.1016/j.numecd.2019.01.016. Epub 2019 Feb 7.
6
Lean non-alcoholic fatty liver disease.非酒精性脂肪肝偏瘦型。
Clin Nutr. 2019 Jun;38(3):975-981. doi: 10.1016/j.clnu.2018.08.008. Epub 2018 Aug 17.
7
Hyperreactivity of Blood Leukocytes in Patients with NAFLD to Ex Vivo Lipopolysaccharide Treatment Is Modulated by Metformin and Phosphatidylcholine but Not by Alpha Ketoglutarate.非酒精性脂肪性肝病患者血液白细胞对体外脂多糖治疗的高反应性受二甲双胍和磷脂酰胆碱调节，而非α-酮戊二酸调节。
PLoS One. 2015 Dec 2;10(12):e0143851. doi: 10.1371/journal.pone.0143851. eCollection 2015.
8
Non-alcoholic fatty liver disease associated with increased arterial stiffness in subjects with normal glucose tolerance, but not pre-diabetes and diabetes.非酒精性脂肪性肝病与糖耐量正常的受试者动脉僵硬度增加有关，但与糖尿病前期和糖尿病患者无关。
Diab Vasc Dis Res. 2015 Sep;12(5):359-65. doi: 10.1177/1479164115585009. Epub 2015 May 25.
9
Increased prevalence and risk of non-alcoholic fatty liver disease in overweight and obese patients with Type 2 diabetes in South China.中国南方超重和肥胖的2型糖尿病患者中非酒精性脂肪性肝病的患病率及风险增加。
Diabet Med. 2017 Apr;34(4):505-513. doi: 10.1111/dme.13174. Epub 2016 Sep 15.
10
Prevalence of undiagnosed diabetes and postchallenge hyperglycaemia in Chinese patients with non-alcoholic fatty liver disease.中国非酒精性脂肪性肝病患者中未诊断糖尿病和糖负荷后高血糖的患病率
Aliment Pharmacol Ther. 2006 Oct 15;24(8):1215-22. doi: 10.1111/j.1365-2036.2006.03112.x.

引用本文的文献

1
Non-alcoholic fatty liver disease, metabolic syndrome, and type 2 diabetes mellitus: where do we stand today?非酒精性脂肪性肝病、代谢综合征与2型糖尿病：我们如今处于什么状况？
Arch Med Sci. 2022 Jun 3;19(4):884-894. doi: 10.5114/aoms/150639. eCollection 2023.

本文引用的文献

1
Comparison of clinical characteristics between lean and obese nonalcoholic fatty liver disease in the northeast Chinese population.中国东北人群中瘦型与肥胖型非酒精性脂肪性肝病临床特征的比较
Arch Med Sci Atheroscler Dis. 2019 Aug 6;4:e191-e195. doi: 10.5114/amsad.2019.87122. eCollection 2019.
2
Lean non-alcoholic fatty liver disease and development of diabetes: a cohort study.瘦型非酒精性脂肪性肝病与糖尿病的发生：队列研究。
Eur J Endocrinol. 2019 Aug;181(2):185-192. doi: 10.1530/EJE-19-0143.
3
Non alcoholic fatty liver disease and risk of incident diabetes in subjects who are not obese.非酒精性脂肪性肝病与非肥胖人群中糖尿病发病风险的关系。
Nutr Metab Cardiovasc Dis. 2019 May;29(5):489-495. doi: 10.1016/j.numecd.2019.01.016. Epub 2019 Feb 7.
4
Different predictors of steatosis and fibrosis severity among lean, overweight and obese patients with nonalcoholic fatty liver disease.非酒精性脂肪性肝病的瘦、超重和肥胖患者中，肝脂肪变性和纤维化严重程度的不同预测因素。
Dig Liver Dis. 2019 Oct;51(10):1392-1399. doi: 10.1016/j.dld.2019.02.019. Epub 2019 Mar 28.
5
Patients With Lean Nonalcoholic Fatty Liver Disease Are Metabolically Abnormal and Have a Higher Risk for Mortality.非酒精性脂肪性肝病瘦型患者存在代谢异常且死亡风险更高。
Clin Diabetes. 2019 Jan;37(1):65-72. doi: 10.2337/cd18-0026.
6
Lean Patients with Non-Alcoholic Fatty Liver Disease Have a Severe Histological Phenotype Similar to Obese Patients.非酒精性脂肪性肝病的瘦患者具有与肥胖患者相似的严重组织学表型。
J Clin Med. 2018 Dec 17;7(12):562. doi: 10.3390/jcm7120562.
7
Lean non-alcoholic fatty liver disease (lean NAFLD): characteristics, metabolic outcomes and risk factors from a 7-year prospective, community cohort study from Sri Lanka.从斯里兰卡一项为期 7 年的前瞻性社区队列研究看瘦型非酒精性脂肪性肝病（瘦型 NAFLD）的特征、代谢结局和危险因素。
Hepatol Int. 2019 May;13(3):314-322. doi: 10.1007/s12072-018-9916-4. Epub 2018 Dec 11.
8
Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.瘦型非酒精性脂肪性肝病患者的肝脏和心血管损伤，及其与内脏肥胖的关系。
Clin Gastroenterol Hepatol. 2017 Oct;15(10):1604-1611.e1. doi: 10.1016/j.cgh.2017.04.045. Epub 2017 May 26.
9
Clinical and Metabolic Characterization of Lean Caucasian Subjects With Non-alcoholic Fatty Liver.非酒精性脂肪肝的瘦白种人受试者的临床和代谢特征
Am J Gastroenterol. 2017 Jan;112(1):102-110. doi: 10.1038/ajg.2016.318. Epub 2016 Aug 16.